Tvardi Therapeutics, Inc. (TVRD) has a market capitalization of $29.65M and trades at $3.16. The 52-week range is 2.81-43.65.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-2.46.
The stock has a beta of 0.13, operates in the Healthcare sector.
